Form 4: Thermo Fisher Scientific CEO Marc Casper Executes Stock Option and Sells Shares Under 10b5-1 Plan
SEC Form 4
Thermo Fisher Scientific's CEO, Marc Casper, exercised stock options and sold shares of common stock under a pre-arranged 10b5-1 trading plan.
Summary
- On October 30 and 31, 2024, Marc N. Casper, Chairman and CEO of Thermo Fisher Scientific, exercised stock options to acquire 20,000 shares of common stock at a price of $210.68 per share.
- Following the exercise of these options, Casper sold a total of 13,942 shares of common stock in multiple transactions at prices ranging from $545.39 to $553.81 per share.
- These transactions were executed under a Rule 10b5-1 trading plan adopted by Casper on November 10, 2023.
- After these transactions, Casper directly owns 121,191.54 shares of Thermo Fisher Scientific common stock.
- Casper also indirectly owns 11,300 shares through the Alison Casper 2020 Irrevocable Trust, 43,608 shares through Floral Park Associates, Inc., and 5,000 shares through the MNC 2020 Irrevocable Trust.
Sentiment
Score: 5
Explanation: The document simply reports stock transactions by an executive, which is a neutral event. The transactions were pre-planned under a 10b5-1 plan.
Industry Context
Executive stock transactions are a common occurrence in publicly traded companies. The use of 10b5-1 trading plans allows insiders to sell shares over a period of time while avoiding concerns about insider trading.
Stakeholder Impact
- The stock sales could have a minor impact on shareholders due to the increased supply of shares in the market, but the effect is likely to be minimal given the relatively small volume of shares sold compared to the company's overall market capitalization.
Key Dates
| Date | Description |
|---|---|
| 11/10/2023 | Date the reporting person adopted the Rule 10b5-1 trading plan |
| 02/27/2019 | First vesting date of stock options |
| 02/27/2020 | Second vesting date of stock options |
| 02/27/2021 | Third vesting date of stock options |
| 02/27/2022 | Fourth vesting date of stock options |
| 02/27/2025 | Expiration date of stock options |
| 10/30/2024 | Date of stock option exercise and share sales |
| 10/31/2024 | Date of stock option exercise and share sales |
| 11/01/2024 | Date of Form 4 filing |
Disclaimer:The information provided here is for general informational purposes only and does not constitute financial advice, recommendation, or endorsement of any kind. It may contain errors or omissions. You should not rely on this information to make financial decisions. Always seek the advice of a qualified financial professional before making any investment or financial decisions. Use of this information is at your own risk.